Literature DB >> 28918516

Valve-sparing aortic root surgery. CON: remodeling.

Takashi Kunihara1.   

Abstract

The two major valve-sparing root replacement procedures, aortic valve reimplantation (reimplantation) and aortic root remodeling (remodeling), have advantages and disadvantages, which are reviewed herein. The main advantage of reimplantation is the resulting annular support, and the disadvantages are the unfavorable hemodynamics and relatively long procedure time. The main advantages of remodeling are the physiological hemodynamics and decreased procedure time, and the disadvantage is the lack of annular support. With technical advances and modifications, however, the differences between these two procedures have narrowed. Application of a graft with sinuses for reimplantation improves the hemodynamics, and addition of annuloplasty to remodeling provides the necessary annular support. Nevertheless, remodeling has some advantages because less root dissection is required and the procedure time is shorter and hemodynamically favorable. Thus, remodeling may be the procedure of choice for high-risk patients (such as those with acute aortic dissection, of advanced age, with reduced ventricular function, or undergoing a concomitant operation). Remodeling may also be best for young athletes because of the hemodynamic advantage. Regardless of the advantages and disadvantages, both procedures provide excellent clinical results in terms of late valve durability. Surgeons should be familiar with both techniques and properly match patients to the appropriate treatment.

Entities:  

Keywords:  Annuloplasty; Aortic root remodeling; Aortic valve reimplantation; Aortic valve repair; Valve-preserving root replacement

Mesh:

Year:  2017        PMID: 28918516     DOI: 10.1007/s11748-017-0833-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  1 in total

Review 1.  Toward standardization of valve-sparing root replacement and annuloplasty.

Authors:  Takashi Kunihara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.